A phase II trial of induction chemotherapy with cisplatin, docetaxel, and capecitabine followed by concurrent cisplatin-radiotherapy in advanced nasopharyngeal carcinoma.

被引：1
|
作者：
Yamouni, M.
Beldjilali, Y.
Benhadji, K. A.
Khellafi, H.
Betkaoui, F.
Kaid, Y.
Benchlef, L.
Daim, F. Z.
Toubal, S.
Boukerche, A.
Abdelaoui, A.
Djellali, L.
机构：
[1] Univ Hosp Oran, Dept Oncol, Oran, Algeria
[2] Univ Hosp Oran, Dept Med Oncol, Oran, Algeria
[3] Univ Hosp Oran, Dept Radiotherapy, Oran, Algeria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.5543
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5543
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase II study of preoperative docetaxel, cisplatin, and capecitabine in patients with gastric carcinoma.
    Voon, Pei-Jye
    Soe, Mu-Yar
    Zee, Ying Kiat
    Chuah, Benjamin
    Lim, Robert S. C.
    Shabbir, Asim
    So, Jimmy
    Yong, Wei-Peng
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [42] Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy or chemoradiotherapy alone in locally advanced non-endemic nasopharyngeal carcinoma
    Ou, Dan
    Blanchard, Pierre
    El Khoury, Clement
    De Felice, Francesca
    Even, Caroline
    Levy, Antonin
    Nguyen, France
    Janot, Francois
    Gorphe, Philippe
    Deutsch, Eric
    Temam, Stephane
    Tao, Yungan
    ORAL ONCOLOGY, 2016, 62 : 114 - 121
  • [43] Induction chemotherapy with docetaxel and cisplatin is highly effective for locally advanced nasopharyngeal carcinoma
    Ekenel, Meltem
    Keskin, Serkan
    Basaran, Mert
    Ozdemir, Canan
    Meral, Rasim
    Altun, Musa
    Aslan, Ismet
    Bavbek, Sevil E.
    ORAL ONCOLOGY, 2011, 47 (07) : 660 - 664
  • [44] Cisplatin and Fluorouracil induction Chemotherapy With or Without Docetaxel in Locoregionally Advanced Nasopharyngeal Carcinoma
    Jin, Ting
    Qin, Wei-feng
    Jiang, Feng
    Jin, Qi-feng
    Wei, Qi-chun
    Jia, Yong-shi
    Sun, Xiao-nan
    Li, Wen-feng
    Chen, Xiao-zhong
    TRANSLATIONAL ONCOLOGY, 2019, 12 (04): : 633 - 639
  • [45] Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer
    Bae, Woo Kyun
    Hwang, Jun Eul
    Shim, Hyun Jeong
    Cho, Sang Hee
    Lee, Joon Kyoo
    Lim, Sang-Chul
    Chung, Woong-Ki
    Chung, Ik-Joo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (03) : 589 - 595
  • [46] Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer
    Woo Kyun Bae
    Jun Eul Hwang
    Hyun Jeong Shim
    Sang Hee Cho
    Joon Kyoo Lee
    Sang-Chul Lim
    Woong-Ki Chung
    Ik-Joo Chung
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 589 - 595
  • [47] The Acute Toxicities and Efficacy of Concurrent Chemotherapy With Docetaxel Plus Cisplatin, or Docetaxel, or Cisplatin and Helical Tomotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized Single-Center Phase II Trial
    Luo, Yanrong
    Cai, Boning
    Li, Bo
    Liu, Fang
    Du, Lei
    Zhao, Dawei
    Fan, Wenjun
    Meng, Linlin
    Zhang, Xinxin
    Ma, Lin
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [48] Induction Chemotherapy with Gemcitabine and Cisplatin followed by Radiochemotherapy in locally advanced Nasopharyngeal Carcinoma
    Luttke, Moritz
    Spath, Richard
    Marschner, Sebastian
    Walter, Franziska
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (08) : 740 - 742
  • [49] Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer
    Bossi, P.
    Orlandi, E.
    Bergamini, C.
    Locati, L. D.
    Granata, R.
    Mirabile, A.
    Parolini, D.
    Franceschini, M.
    Fallai, C.
    Olmi, P.
    Quattrone, P.
    Potepan, P.
    Gloghini, A.
    Miceli, R.
    Mattana, F.
    Scaramellini, G.
    Licitra, L.
    ANNALS OF ONCOLOGY, 2011, 22 (11) : 2495 - 2500
  • [50] Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer
    Jae-Sung Kim
    Joo Han Lim
    Jee Hyun Kim
    Seock-Ah Im
    Eui Kyu Chie
    Jin-Hyeok Hwang
    Tae-You Kim
    Yung-Jue Bang
    Sung Whan Ha
    Yong Bum Yoon
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 381 - 389
12345